亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Method for Regulating Apoptosis

技術優勢

High degree of conservation among fission and fusion proteins Alternative target for therapeutic attenuation of apoptosis Target dynamins and thus prevents cells from dying

技術應用

Treat conditions associated with apoptosis Mycocardial infarction, cancer, Parkinson's disease, amyotrophic lateral sclerosis (ALS), and and neurodegenerative diseases

詳細技術說明

A method for inhibiting cellular apoptosis through the regulation of mitochondrial fission and fusion has been identified by researchers at the University of California, Davis. The method for identifying small molecule inhibitors of mitochondrial fission fusion is described. Such compounds can be capable of regulating cellular apoptosis via their effects on mitochondrial membrane dynamics. UC Davis investigators have verified compound activities in both yeast and mammalian cell systems. Studies have indicated that one compound acts through the mediation of the mitochondrial fission dynamin related GTPase. In addition, UC Davis researchers have discovered that a small molecule inhibitor of Drp1, the mitochondrial division dynamin, blocks the mitochondrial outer membrane permeabilization in isolated mitochondria, the first step in apoptosis induced by truncated Bid (tBid). The new compound is termed mdivi-1.

附加資料

Patent Number: US8450333B2
Application Number: US200828536A
Inventor: Nunnari, Jodi | Cassidy-Stone, Ann | Kurth, Mark
Priority Date: 9 Jun 2003
Priority Number: US8450333B2
Application Date: 8 Feb 2008
Publication Date: 28 May 2013
IPC Current: A01N004354 | A61K0031517 | C07D023972 | C07D023995 | C07D027736 | C07D027738 | C07D040914 | C07D049804 | C07D051304
US Class: 51426631 | 544285
Assignee Applicant: The Regents of the University of California
Title: Molecules for regulating cell death
Usefulness: Molecules for regulating cell death
Summary: For preparing composition useful for modulating mitochondrial fission in a cell; inhibiting or decreasing apoptosis in a cell and treating condition associated with apoptosis, e.g. Parkinson's disease, amyotrophic lateral sclerosis (ALS), stroke, heart attack, congestive heart failure, transplantation, alcoholic hepatitis, and drug-induced liver toxicity (claimed); decreasing cell or tissue damage; inhibiting mitochondrial fusion used to treat conditions associated with increasing apoptosis, e.g. neoplasia, cancer, and tumor; and also used to identify other molecules that modulate apoptosis by competition assays.
Novelty: New substituted mercaptoquinazolin-4(3H)-one compound useful as mitochondrial dynamin-related guanosine triphosphatase (GTPase) inhibitor for treating condition associated with apoptosis e.g. Parkinson's disease, stroke, heart attack